Skip to main content
PYXS logo
PYXS
(NASDAQ)
Pyxis Oncology, Inc.
$1.48-- (--)
Loading... - Market loading

Pyxis Oncology (PYXS) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Pyxis Oncology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Pyxis Oncology, Inc. (PYXS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents15.4219.479.66179.29274.748.0819.69
Short-Term Investments51.44107.46109.630.000.000.000.00
Cash & Short-Term Investments66.86126.93119.30179.29274.748.0819.69
Accounts Receivable0.700.000.020.600.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets2.495.515.291.313.940.020.01
Total Current Assets72.11132.44124.60186.61278.678.1019.70
Non-Current Assets
Property, Plant & Equipment (Net)19.4222.1424.8124.771.241.940.08
Intangible Assets0.002.6024.310.000.000.000.00
Other Non-Current Assets0.000.000.000.000.110.110.03
Total Non-Current Assets19.4224.7449.1224.771.352.050.11
Total Assets91.52157.18173.73211.38280.0210.1519.81
Current Liabilities
Accounts Payable10.894.863.907.1011.951.080.49
Short-Term Debt0.002.901.230.000.170.620.01
Accrued Liabilities4.816.7512.6223.453.361.880.00
Deferred Revenue0.000.007.660.000.000.000.00
Other Current Liabilities0.439.9212.971.096.591.930.12
Total Current Liabilities21.1317.6825.7631.6318.713.690.73
Non-Current Liabilities
Long-Term Debt16.9818.7520.1018.920.000.170.01
Deferred Tax Liabilities0.000.002.160.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.0021.9421.94
Total Non-Current Liabilities16.9818.7522.2618.920.0022.1121.95
Total Liabilities38.1136.4348.0250.5618.7125.8022.68
Stockholders' Equity
Common Stock0.060.060.050.030.030.000.00
Retained Earnings-443.18-363.56-286.23-212.44-91.72-15.74-2.92
Accumulated Other Comprehensive Income0.050.170.060.000.000.000.00
Additional Paid-in Capital496.47484.08411.82373.23353.000.100.04
Shares Outstanding62.6959.9744.7534.9632.220.000.00
Total Stockholders' Equity53.41120.75125.70160.82261.31-15.65-2.87
Total Liabilities & Equity91.52157.18173.73211.38280.0210.1519.81

Frequently Asked Questions About Pyxis Oncology Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is PYXS's debt level?

Review Pyxis Oncology's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.